Validation and comparison of prognostic scoring systems in patients with head and neck squamous cell carcinoma treated with nivolumab.

Yukinori TakenakaNorihiko TakemotoTomoyuki OtsukaMinako NishioMasashi TanidaTakashi FujiiKazuki HayashiMotoyuki SuzukiMasashi MoriYoshifumi YamamotoAtsuhiko UnoHidenori Inohara

Published in: Japanese journal of clinical oncology (2024)

MD Anderson Cancer Center + neutrophil-to-lymphocyte ratio and Hammersmith scoring systems were better predictors of prognosis in patients with head and neck squamous cell carcinoma treated with nivolumab.

Keyphrases

papillary thyroid
squamous cell
molecular dynamics
newly diagnosed